Don’t miss the latest developments in business and finance.

Balaxi Pharmaceuticals consolidated net profit declines 68.19% in the September 2024 quarter

Image
Last Updated : Nov 05 2024 | 4:50 PM IST

Sales rise 41.41% to Rs 77.38 crore

Net profit of Balaxi Pharmaceuticals declined 68.19% to Rs 4.59 crore in the quarter ended September 2024 as against Rs 14.43 crore during the previous quarter ended September 2023. Sales rose 41.41% to Rs 77.38 crore in the quarter ended September 2024 as against Rs 54.72 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var.Sales77.3854.72 41 OPM %13.6919.66 -PBDT6.0310.67 -43 PBT5.5610.01 -44 NP4.5914.43 -68

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

More From This Section

First Published: Nov 05 2024 | 4:37 PM IST

Next Story